A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania

RATIONALE: Lithium is an effective prophylactic and anti-manic treatment in bipolar disorder; however, its use is declining through perceived poor tolerance and toxicity. Lithium inhibits inositol monophosphatase (IMPase), a probable key therapeutic mechanism. The anti-inflammatory drug, ebselen, al...

全面介紹

Na minha lista:
書目詳細資料
發表在:Psychopharmacology (Berl)
Main Authors: Sharpley, Ann L, Williams, Clare, Holder, Adele A, Godlewska, Beata R, Singh, Nisha, Shanyinde, Milensu, MacDonald, Orla, Cowen, Philip J
格式: Artigo
語言:Inglês
出版: Springer Berlin Heidelberg 2020
主題:
Original Investigation
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7683468/
https://ncbi.nlm.nih.gov/pubmed/32909076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-020-05654-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍